Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.240
+0.150 (7.18%)
Apr 29, 2025, 11:40 AM EDT - Market open
Innate Pharma Employees
Innate Pharma had 181 employees as of December 31, 2024. The number of employees increased by 2 or 1.12% compared to the previous year.
Employees
181
Change (1Y)
2
Growth (1Y)
1.12%
Revenue / Employee
$115,090
Profits / Employee
-$282,970
Market Cap
174.32M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
IPHA News
- 5 days ago - Innate Pharma Announces €15M Investment by Sanofi - Business Wire
- 6 days ago - Innate Pharma Regains Its Rights on CD123 Targeting ANKET® and Announces Sanofi's Intention to Make a Strategic Investment in the Company - Business Wire
- 13 days ago - Innate Pharma Proposes to Its Shareholders to Transform Its Corporate Governance Structure Into a Board of Directors and to Change Its Composition - Business Wire
- 13 days ago - Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025 - Business Wire
- 26 days ago - Innate Pharma to Participate in the 2025 Stifel Virtual Targeted Oncology Forum - Business Wire
- 4 weeks ago - Innate Pharma S.A. (IPHA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Innate Pharma Reports Full Year 2024 Financial Results and Business Update - Business Wire
- 4 weeks ago - Innate Pharma Highlights Antibody Drug Conjugate IPH4502 Abstract Selected for the AACR 2025 Annual Meeting - Business Wire